Zhengye Biotechnology

ZYBTNasdaq China Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$63.978 M

$1.35 -1.46%

Close of 21 Sept 2026

Revenue

$16.6M

#3045 by revenue

Earnings

-$9.98M

Loss-making

Shares outstanding

47,391,376

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#338CleneCLNN$64.5M
#339Boundless BioBOLD$64.4M
#340Zhengye BiotechnologyZYBT$64.0M
#341IntercureINCR$62.1M
#342PDS BiotechnologyPDSB$61.0M

What if Zhengye Biotechnology were worth as much as…

Open the what-if tool →

Gold $30.3T

$638,809.35

Per share 473,192× higher

Bitcoin $1.72T

$36,289.38

Per share 26,881× higher

Nvidia $5.48T

$115,629.86

Per share 85,652× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Zhengye Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.